Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.5 instead of v3.5.4, indicating a newer build of the page. This appears to be a backend/version update with no visible content changes.
    Difference
    0.0%
    Check dated 2026-06-06T18:33:31.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4 instead of v3.5.3, indicating a new release of the page/template. No study data or content appears to be changed.
    Difference
    0.0%
    Check dated 2026-05-15T23:53:01.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-23T15:01:05.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Added the MeSH term Malignant lymphoma, large B-cell, diffuse. Introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:43:31.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:10:05.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added new revision entry v3.4.3 with March 2026 dates; removed prior revision entry v3.4.2 and February 2026 dates.
    Difference
    0.3%
    Check dated 2026-03-11T14:41:12.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.